CIDRAP newsletters options
Though influenza A is still dominant, some countries are seeing influenza B rises.
More than half of the antibiotics prescribed by VA dentists in 2019 do not have guidelines supporting their use.
The Minimized Risk of Antimicrobial Resistance certification is given to manufacturing sites that have demonstrated a commitment to controlling antibiotic discharge.
The most common symptom throughout the study period was rash, followed by enlarged lymph nodes.
In 2021, the US RN workforce decreased by more than 100,000 employees.
Just over 40% of mothers said their young babies had received Beyfortus, the new RSV antibody vaccine.
In hard-hit Brazil, the health ministry has asked the Fiocruz Institute to double its dengue test production.
Vaccine halved risk of medically attended COVID, reduced H1N1 flu risk by 60%.
At least 10 people have been sickened by E coli in an outbreak tied to raw milk cheese, and a Salmonella outbreak linked to charcuterie meats has grown to 70 cases.
The study also found "severely high" levels of resistance to first-line treatments for UTIs in Tanzania, Kenya, and Uganda.
Two people had connections to camels, but the exposure source is still unknown for two of the patients.
Several states have now reported cases amid a global spike in measles activity.
Researchers say the findings highlight the need for updated testing and treatment guidelines for the sexually transmitted bacteria.
Influenza B proportions are rising in regions where flu activity is trending upward.
The report from the Global Coalition on Aging and the Infectious Diseases Society of America assesses how 11 high-income nations are addressing AMR.
Increased activity continues into the new year, with gaps in vaccine coverage and the season's peak still ahead.
High-incidence jurisdictions now report cases based on lab results alone rather than lab data plus clinical information.
Researcher says ongoing surveillance is needed to ensure that women receive optimal empiric antibiotics for uncomplicated UTIs.
Both controls and cases in the trial had an approximate mortality rate of 15% at day 90.
After 55% of a prison population agreed to be immunized, no further cases were detected.
